JP2015517520A5 - - Google Patents

Download PDF

Info

Publication number
JP2015517520A5
JP2015517520A5 JP2015512636A JP2015512636A JP2015517520A5 JP 2015517520 A5 JP2015517520 A5 JP 2015517520A5 JP 2015512636 A JP2015512636 A JP 2015512636A JP 2015512636 A JP2015512636 A JP 2015512636A JP 2015517520 A5 JP2015517520 A5 JP 2015517520A5
Authority
JP
Japan
Prior art keywords
composition
subject
cells
cell
brain injury
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015512636A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015517520A (ja
JP6134783B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/030895 external-priority patent/WO2013172944A1/en
Publication of JP2015517520A publication Critical patent/JP2015517520A/ja
Publication of JP2015517520A5 publication Critical patent/JP2015517520A5/ja
Application granted granted Critical
Publication of JP6134783B2 publication Critical patent/JP6134783B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015512636A 2012-05-16 2013-03-13 外傷性脳損傷の処置のため、および神経因性細胞の移動の調節のための方法および組成物 Active JP6134783B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261647893P 2012-05-16 2012-05-16
US61/647,893 2012-05-16
PCT/US2013/030895 WO2013172944A1 (en) 2012-05-16 2013-03-13 Methods and compositions for treatment of traumatic brain injury and for modulation of migration of neurogenic cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016184086A Division JP2016220694A (ja) 2012-05-16 2016-09-21 外傷性脳損傷の処置のため、および神経因性細胞の移動の調節のための方法および組成物

Publications (3)

Publication Number Publication Date
JP2015517520A JP2015517520A (ja) 2015-06-22
JP2015517520A5 true JP2015517520A5 (https=) 2015-10-29
JP6134783B2 JP6134783B2 (ja) 2017-05-24

Family

ID=48040424

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2015512636A Active JP6134783B2 (ja) 2012-05-16 2013-03-13 外傷性脳損傷の処置のため、および神経因性細胞の移動の調節のための方法および組成物
JP2016184086A Pending JP2016220694A (ja) 2012-05-16 2016-09-21 外傷性脳損傷の処置のため、および神経因性細胞の移動の調節のための方法および組成物
JP2018082259A Pending JP2018111733A (ja) 2012-05-16 2018-04-23 外傷性脳損傷後のバイオブリッジ形成時に発現する組成物
JP2021038508A Pending JP2021098738A (ja) 2012-05-16 2021-03-10 外傷性脳損傷後のバイオブリッジ形成時に発現する組成物
JP2023078339A Pending JP2023099213A (ja) 2012-05-16 2023-05-11 外傷性脳損傷後のバイオブリッジ形成時に発現する組成物
JP2025030492A Pending JP2025098021A (ja) 2012-05-16 2025-02-27 外傷性脳損傷後のバイオブリッジ形成時に発現する組成物

Family Applications After (5)

Application Number Title Priority Date Filing Date
JP2016184086A Pending JP2016220694A (ja) 2012-05-16 2016-09-21 外傷性脳損傷の処置のため、および神経因性細胞の移動の調節のための方法および組成物
JP2018082259A Pending JP2018111733A (ja) 2012-05-16 2018-04-23 外傷性脳損傷後のバイオブリッジ形成時に発現する組成物
JP2021038508A Pending JP2021098738A (ja) 2012-05-16 2021-03-10 外傷性脳損傷後のバイオブリッジ形成時に発現する組成物
JP2023078339A Pending JP2023099213A (ja) 2012-05-16 2023-05-11 外傷性脳損傷後のバイオブリッジ形成時に発現する組成物
JP2025030492A Pending JP2025098021A (ja) 2012-05-16 2025-02-27 外傷性脳損傷後のバイオブリッジ形成時に発現する組成物

Country Status (7)

Country Link
US (4) US9828593B2 (https=)
EP (1) EP2849766B1 (https=)
JP (6) JP6134783B2 (https=)
CN (3) CN104519891B (https=)
AU (2) AU2013263417B2 (https=)
CA (1) CA2872188C (https=)
WO (1) WO2013172944A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104519891B (zh) 2012-05-16 2019-03-22 桑比欧公司 用于治疗创伤性脑损伤和用于调节神经原性细胞迁移的方法和组合物
WO2014058464A1 (en) 2012-10-09 2014-04-17 Sanbio, Inc. Methods and compositions for treatment of retinal degeneration
WO2015120388A1 (en) * 2014-02-10 2015-08-13 Cytori Therapeutics, Inc. Regenerative cell therapy for central nervous system (cns) disorders and ptsd
HK1247080A1 (zh) 2015-04-01 2018-09-21 桑比欧公司 用於刺激细胞增殖和提供fgf2同种型的生物活性混合物的方法和组合物
KR101986366B1 (ko) * 2016-02-26 2019-06-07 주식회사 이노퓨틱스 Nurr1과 Foxa2의 교질세포 기능 조절에 의한 염증성 신경질환 치료
EP3423070B1 (en) * 2016-03-03 2022-05-04 Henry Ford Health System 3-d collagen scaffold-generated exosomes and uses thereof
WO2018125829A1 (en) * 2016-12-28 2018-07-05 Sanbio, Inc. Cell delivery system and methods of operation thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US20030003090A1 (en) 2001-05-31 2003-01-02 Prockop Darwin J. Directed in vitro differentiation of marrow stromal cells into neural cell progenitors
JP3886346B2 (ja) 2001-06-22 2007-02-28 サンバイオ,インコーポレイティド 骨髄間質細胞由来Schwann細胞を含む神経再生用医薬組成物
DK1479767T3 (da) * 2002-02-06 2013-11-25 Sanbio Inc Fremgangsmåde til differentiering/inducering af stromaceller fra knoglemarv til nerveceller ved overføring af Notch-gen
US20050032827A1 (en) 2003-06-12 2005-02-10 Donna Oksenberg Sigma ligands for neuronal regeneration and functional recovery
EP1737950B9 (en) 2004-04-12 2012-04-18 Sanbio, Inc. Cells exhibiting neuronal progenitor cell characteristics
PT1855700E (pt) * 2005-03-07 2013-12-10 Sanbio Inc Utilização de materiais para tratamento de lesões do sistema nervoso central
CN101008033A (zh) * 2006-01-27 2007-08-01 陈云 功能性中枢神经损伤诊断检测用基因芯片及其制造方法
WO2008102460A1 (en) 2007-02-23 2008-08-28 Sanbio Inc. Transplantation of bone marrow stromal cell-induced neural stem cells for promoting fuctional recovery after spinal cord injury
US8945919B2 (en) * 2007-08-15 2015-02-03 San Bio, Inc. Methods and composition for treating neural degeneration
EP2215216B1 (en) 2007-12-03 2018-05-30 SanBio, Inc. Extracellular matrix from pluripotent cells
PT2222839E (pt) 2007-12-03 2015-11-30 Sanbio Inc Métodos e composições para modular a diferenciação de células pluripotentes
ES2594229T3 (es) 2008-04-30 2016-12-16 Sanbio, Inc. Células de regeneración nerviosa con alteraciones en la metilación del ADN
EP2694080B1 (en) 2011-04-06 2018-03-14 SanBio, Inc. Methods and compositions for modulating peripheral immune function
US20120263681A1 (en) 2011-04-12 2012-10-18 Fujifilm Corporation Composition comprising cell and biocompatible polymer
JP6306506B2 (ja) 2011-08-19 2018-04-04 サンバイオ,インコーポレイティド 神経原生及びグリア原生因子及びそれらについてのアッセイ
CN112386681A (zh) 2012-01-27 2021-02-23 桑比欧公司 用于调节血管生成和血管发生的方法和组合物
CN104519891B (zh) 2012-05-16 2019-03-22 桑比欧公司 用于治疗创伤性脑损伤和用于调节神经原性细胞迁移的方法和组合物

Similar Documents

Publication Publication Date Title
JP2015517520A5 (https=)
WO2015031654A3 (en) Systems, compositions, and methods for transplantation and treating conditions
WO2020047467A3 (en) Cardiac cell reprogramming with myocardin and ascl1
MX2021003702A (es) Uso de importadores de sustrato para la exportación de oligosacáridos.
WO2013013025A3 (en) Anti-cxcr4 antibodies and methods of use
SA522432139B1 (ar) بروتينات ربط متعددة الخصوصية لمعالجة السرطان
GB201315212D0 (en) Systems, compositions and methods for transplantation
WO2014089169A4 (en) Immunotherapy with binding agents
SG10201809146QA (en) Recombinant host cell engineered to overexpress helper proteins
JP2015131795A5 (https=)
WO2016081032A3 (en) Mesenchymal stem cells derived from induced pluripotent stem cells
EA201270713A1 (ru) Белки на основе фибронектина с каркасными доменами, которые связывают ил-23
JP2016501515A5 (https=)
Kelly et al. TNF receptor 2, not TNF receptor 1, enhances mesenchymal stem cell-mediated cardiac protection following acute ischemia
EA201790025A1 (ru) Создание банка мезенхимальных стромальных клеток из объединенных мононуклеарных клеток нескольких доноров костного мозга
MY165499A (en) Monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
WO2016063026A3 (en) Selective nav protein binders
EA201400401A1 (ru) Биокомпозит для регенерации поврежденных тканей и органов, набор для изготовления биокомпозита и способ лечения
JP2017536826A5 (https=)
HK1218515A1 (zh) 来自胎盘的自然杀伤细胞
ZA202100888B (en) Methods of preparing personalized blood vessels
MX374489B (es) Formulación de una composición sanguínea rica en plaquetas y/o factores de crecimiento, con proteínas gelificadas, y método de preparación de la misma.
JP2017039729A5 (https=)
EA201490995A1 (ru) Использование фо-ти для усиления мобилизации и пролиферации стволовых клеток
WO2015181831A3 (en) A method for targettingglioblastoma with wharton jelly-mesenchymal stem cells (wj-msc) derived from human umbilical cord